Products

Anti-C5 Therapeutic Antibody (137-26) (TAB-1382CL)

MAb 137-26 can effectively neutralize the inflammatory effects of C5a, but still allow other components of the complement cascade, including C3 and C5b-9, to mediate anti-bacterial functions. This pharmacological property is exceptionally important with respect to the treatment of bacterial sepsis, chronic IC diseases, and psoriasis.      

Specifications
Immunogen
C5 purified from human sera
Host
Mouse
Specificity
Human
Clone
137-26
Related Disease
Bacterial sepsis, chronic IC diseases, and psoriasis
Target
Alternative Names
C5; complement component 5; C5D; C5a; C5b; ECLZB; CPAMD4; complement C5
Entrez Gene ID
727
UniProt ID
P01031

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-381-2994    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2018 Creative-Biolabs All Rights Reserved